Marvin 03021214042D 24 28 0 0 1 0 999 V2000 12.5013 -7.3141 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.3977 -5.2151 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.9561 -6.0123 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 11.0479 -8.9402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 13.2364 -6.0908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.5144 -6.4902 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 13.9849 -6.2765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.7802 -6.7757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.2315 -5.2713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.0871 -6.4631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.6970 -6.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.5336 -6.4727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9792 -4.9609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.0760 -7.2884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.8106 -6.0598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.7824 -7.7130 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 15.3387 -6.6979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.7014 -5.2174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.5363 -5.6194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.3831 -6.0408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.3568 -7.6897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.6635 -6.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.6483 -7.2668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.7693 -8.5386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 6 1 0 0 0 0 1 16 1 0 0 0 0 2 20 1 0 0 0 0 3 22 1 0 0 0 0 4 24 1 0 0 0 0 6 5 1 1 0 0 0 5 7 1 0 0 0 0 5 8 1 0 0 0 0 5 9 1 0 0 0 0 6 15 1 0 0 0 0 7 11 1 0 0 0 0 8 12 1 0 0 0 0 9 13 1 0 0 0 0 10 14 2 0 0 0 0 10 15 1 0 0 0 0 10 20 1 0 0 0 0 11 17 1 0 0 0 0 11 18 1 0 0 0 0 12 17 1 0 0 0 0 12 19 1 0 0 0 0 13 18 1 0 0 0 0 13 19 1 0 0 0 0 14 16 1 0 0 0 0 14 21 1 0 0 0 0 16 24 1 1 0 0 0 20 22 2 0 0 0 0 21 23 2 0 0 0 0 22 23 1 0 0 0 0 M END > CHEBI:64080 > (1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol > An isochromene that is 3,4-dihydroisochromene-5,6-diol bearing additional aminomethyl and 1-adamantyl substituents at positions 1 and 3 respectively (the 1R,3S-diastereomer). Potent and selective dopamine D1-like receptor agonist (pEC50 values are 8.97 and < 5 for D1-like and D2-like receptors respectively). Displays anti-Parkinsonian activity following oral administration in vivo. > 3 > A77636; A-77636; A 77636 > (1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydro-1H-isochromene-5,6-diol > C20H27NO3 > 329.43330 > 329.19909 > 0 > NC[C@@H]1O[C@@H](Cc2c(O)c(O)ccc12)C12CC3CC(CC(C3)C1)C2 > InChI=1S/C20H27NO3/c21-10-17-14-1-2-16(22)19(23)15(14)6-18(24-17)20-7-11-3-12(8-20)5-13(4-11)9-20/h1-2,11-13,17-18,22-23H,3-10,21H2/t11?,12?,13?,17-,18-,20?/m0/s1 > QLJOSZATCBCBDR-DFKUFRTHSA-N > 5855679 > LSM-20969 $$$$